# Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition

> **NCT01170182** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Omeprazole
- **DEVICE:** Prilosec® 40 mg

## Key facts

- **NCT ID:** NCT01170182
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2010-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170182, "Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01170182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*